CD38 and type 2 diabetes mellitus: Thus, Ikehata et al., set the cut of value as mean + 3 SD (8.02) of non-diabetic controls and revealed that 52 of 377 (13.8%) patients with type 2 diabetes had anti-CD38 autoantibodies [30].